openPR Logo
Press release

Biliary Tract Cancer Market and Epidemiology 2032 by DelveInsight | Companies - Incyte Corporation, Loxo Oncology, Bayer, Roche, Genentech, QED Therapeutics, Agios Pharmaceuticals, Servier Pharmaceuticals, Merck Sharp & Dohme, AstraZeneca

06-01-2023 12:16 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Biliary Tract Cancer Market

Biliary Tract Cancer Market

(Albany, USA) DelveInsight's "Biliary Tract Cancer (BTC) Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Biliary Tract Cancer, historical and forecasted epidemiology as well as the Biliary Tract Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Some of the key takeaways from Biliary Tract Cancer market report are:
• Biliary Tract Cancer market size was USD 553 million which is expected to rise during the study period (2019-2032).
• Leading Biliary Tract Cancer companies working in the market are Incyte Corporation, Loxo Oncology, Bayer, Roche, Genentech, QED Therapeutics, Agios Pharmaceuticals, Servier Pharmaceuticals, Merck Sharp & Dohme, AstraZeneca, Taiho Oncology, Delcath Systems, Eisai, TransThera Sciences (Nanjing), Basilea Pharmaceutica, Zymeworks, BeiGene and others.
• Promising Biliary Tract Cancer therapies in the pipeline are Keytruda (pembrolizumab), Imfinzi (durvalumab), Futibatinib (TAS-120), Melphalan, E7090 (tasurgratinib), TT-00420, ARQ 087 (Derazantinib), Lenvima (lenvatinib), Zanidatamab, and others.
• The total Biliary Tract Cancer market size by therapies for early stage disease in the year 2021 was USD 44.84 million which is expected to grow during the study period (2019-2032) in the 7MM.
Biliary tract cancers Overview:
Hepatocellular carcinoma (HCC), biliary tract cancer (BTC), and other metastatic diseases are among the most common malignant hepatic lesions. Biliary tract cancer (BTC) is an epithelial malignancy of the biliary tree that includes the following: GBC and Cholangiocarcinoma (CCA). The symptoms of biliary tract cancer vary depending on the location of the tumor and can include pruritus, abdominal pain, malaise, fatigue, jaundice, pale stool or clay-colored stools, and dark urine, palpable gallbladder, painless jaundice, which is the presenting symptom in 90% of perihilar cholangiocarcinoma (pCCA), and others.

To know in detail about the Biliary Tract Cancer market and epidemiology trends, click here @ https://www.delveinsight.com/report-store/biliary-tract-cancers-btcs-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Biliary Tract Cancer (BTC), also known as Cholangiocarcinoma (CCA) is a rare and heterogeneous malignant neoplasm with epithelial cell origin of biliary duct and histologic and biochemical features of cholangiocyte differentiation.
The malignant tumor may arise from any portion of the bile duct i.e., from terminal ductules (canals of Hering) to the ampulla of Vater, as well as at the peribiliary glands (intramural and extramural) and sometimes may affect gall bladder.

Scope of the Biliary Tract Cancer market report:
• The report covers the descriptive overview of Biliary Tract Cancers (BTCs), explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
• Comprehensive insight has been provided into the Biliary Tract Cancers (BTCs) epidemiology and treatment in the 7MM
• Additionally, an all-inclusive account of both the current and emerging therapies for Biliary Tract Cancers (BTCs) are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
• A detailed review of Biliary Tract Cancers (BTCs) market; historical and forecasted is included in the report, covering drug outreach in the 7MM
• The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Biliary Tract Cancers (BTCs) market

To know more about the Biliary Tract Cancer market report offerings, click here@ https://www.delveinsight.com/sample-request/biliary-tract-cancers-btcs-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Biliary Tract Cancer Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted Biliary Tract Cancer epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Biliary Tract Cancer Epidemiology Segmentation:
The Biliary Tract Cancer market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Biliary Tract Cancer
• Prevalent Cases of Biliary Tract Cancer by severity
• Gender-specific Prevalence of Biliary Tract Cancer
• Diagnosed Cases of Biliary Tract Cancer

Key Biliary Tract Cancer Market Players:
Biliary Tract Cancer companies working in the market are Incyte Corporation, Loxo Oncology, Bayer, Roche, Genentech, QED Therapeutics, Agios Pharmaceuticals, Servier Pharmaceuticals, Merck Sharp & Dohme, AstraZeneca, Taiho Oncology, Delcath Systems, Eisai, TransThera Sciences (Nanjing), Basilea Pharmaceutica, Zymeworks, BeiGene and others.

To know about the Biliary Tract Cancer companies and pipeline drugs, click here@ https://www.delveinsight.com/sample-request/biliary-tract-cancers-btcs-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Biliary Tract Cancer Drugs:
Some of the Biliary Tract Cancer therapies covered in the report are Ivosidenib, Pemigatinib, Melphalan Hydrochloride, Infigratinib, Acelarin, and Many Others.

Scope of the Biliary Tract Cancer Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Biliary Tract Cancer Companies: Incyte Corporation, Loxo Oncology, Bayer, Roche, Genentech, QED Therapeutics, Agios Pharmaceuticals, Servier Pharmaceuticals, Merck Sharp & Dohme, AstraZeneca, Taiho Oncology, Delcath Systems, Eisai, TransThera Sciences (Nanjing), Basilea Pharmaceutica, Zymeworks, BeiGene and others.
• Key Biliary Tract Cancer Therapies: Ivosidenib, Pemigatinib, Melphalan Hydrochloride, Infigratinib, Acelarin, and Many Others.
• Biliary Tract Cancer Therapeutic Assessment: Biliary Tract Cancer current marketed and Biliary Tract Cancer emerging therapies
• Biliary Tract Cancer Market Dynamics: Biliary Tract Cancer market drivers and Biliary Tract Cancer market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Biliary Tract Cancer Unmet Needs, KOL's views, Analyst's views, Biliary Tract Cancer Market Access and Reimbursement

Request a sample to know more about the recent developments in Biliary Tract Cancer treatment landscape @ https://www.delveinsight.com/sample-request/biliary-tract-cancers-btcs-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Contents:
1. Key Insights
2. Executive Summary of Biliary Tract Cancers (BTCs)
3. Competitive Intelligence Analysis for Biliary Tract Cancers (BTCs)
4. Biliary Tract Cancers (BTCs): Market Overview at a Glance
5. Biliary Tract Cancers (BTCs): Disease Background and Overview
6. Biliary Tract Cancer Patient Journey
7. Biliary Tract Cancers (BTCs) Epidemiology and Patient Population
8. Biliary Tract Cancer Treatment Algorithm, Current Treatment, and Medical Practices
9. Biliary Tract Cancer Unmet Needs
10. Key Endpoints of Biliary Tract Cancers (BTCs) Treatment
11. Biliary Tract Cancer Marketed Products
12. Emerging Biliary Tract Cancer Therapies
13. Biliary Tract Cancers (BTCs): Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Biliary Tract Cancer Market Outlook
16. Access and Reimbursement Overview of Biliary Tract Cancers (BTCs)
17. Biliary Tract Cancer KOL Views
18. Biliary Tract Cancer Market Drivers
19. Biliary Tract Cancer Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight

Request a free sample report of Biliary Tract Cancer market to get deep insights into Biliary Tract Cancer unmet needs, drivers and barriers, KOL Views and SWOT Analysis @ https://www.delveinsight.com/sample-request/biliary-tract-cancers-btcs-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Trending Reports
• Familial Primary Pulmonary Hypertension Market: https://www.delveinsight.com/report-store/familial-primary-pulmonary-hypertension-market
• Bacterial Meningitis Market: https://www.delveinsight.com/report-store/bacterial-meningitis-market
• Anaphylaxis Market: https://www.delveinsight.com/blog/food-allergy-treatment-landscape
• Choroidal Neovascularization Market: https://www.delveinsight.com/sample-request/choroidal-neovascularization-market
• Scleroderma Market: https://www.delveinsight.com/report-store/localized-scleroderma-market
• Bladder Cancer Market: https://www.delveinsight.com/report-store/bladder-cancer-market
• Trigeminal Neuralgia Market Size: https://www.delveinsight.com/report-store/trigeminal-neuralgia-market
• Generalized Anxiety Disorder Market: https://www.delveinsight.com/report-store/generalized-anxiety-disorder-gad-market
• Ankylosing Spondylitis Market: https://www.delveinsight.com/infographics/ankylosing-spondylitis-as-market
• Automated External Defibrillators Market: https://www.delveinsight.com/report-store/automated-external-defibrillator-aed-market
• Biliary Tumor Market: https://www.delveinsight.com/report-store/biliary-tract-cancers-btcs-market
• Chronic Insomnia Market: https://www.delveinsight.com/report-store/chronic-insomnia-market
• Chronic Lymphocytic Leukemia Market: https://www.delveinsight.com/report-store/chronic-lymphocytic-leukemia-cll-market
• Eczema Market: https://www.delveinsight.com/report-store/atopic-dermatitis-market
• Helicobacter Pylori Infection Market: https://www.delveinsight.com/report-store/helicobacter-pylori-h-pylori-infection-market

Contact Us
Ankit Nigam
info@delveinsight.com
+1(919)321-6187
https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biliary Tract Cancer Market and Epidemiology 2032 by DelveInsight | Companies - Incyte Corporation, Loxo Oncology, Bayer, Roche, Genentech, QED Therapeutics, Agios Pharmaceuticals, Servier Pharmaceuticals, Merck Sharp & Dohme, AstraZeneca here

News-ID: 3074654 • Views:

More Releases from DelveInsight Business Research

Niemann-Pick Type C Pipeline Report Showcases Emerging Drugs and Leading Companies
Niemann-Pick Type C Pipeline Report Showcases Emerging Drugs and Leading Compani …
DelveInsight's, "Niemann Pick C Disease Pipeline Insight, 2025" report provides comprehensive insights about 10+ companies and 15+ pipeline drugs in Niemann Pick C Disease pipeline landscape. It covers the Niemann-Pick Type C pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Niemann-Pick Type C pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this
Pemphigus Vulgaris Market Positioned for Accelerated Development Through 2034, DelveInsight Finds
Pemphigus Vulgaris Market Positioned for Accelerated Development Through 2034, D …
DelveInsight's "Pemphigus Vulgaris Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Pemphigus Vulgaris, historical and forecasted epidemiology as well as the Pemphigus Vulgaris market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Pemphigus Vulgaris market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Pemphigus Vulgaris Market Forecast https://www.delveinsight.com/sample-request/pemphigus-vulgaris-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the
Osteogenesis Imperfecta Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes
Osteogenesis Imperfecta Market to Evolve Rapidly Over the Next Decade by 2034, D …
The Osteogenesis Imperfecta market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Osteogenesis Imperfecta pipeline products will significantly revolutionize the Osteogenesis Imperfecta market dynamics. DelveInsight's "Osteogenesis Imperfecta Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Osteogenesis Imperfecta, historical and forecasted epidemiology as well as the Osteogenesis Imperfecta market trends in the United
Myopic Macular Degeneration Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates
Myopic Macular Degeneration Market Insights Highlight Expanding Outlook Till 203 …
DelveInsight's "Myopic Macular Degeneration Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Myopic Macular Degeneration, historical and forecasted epidemiology as well as the Myopic Macular Degeneration market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. The latest healthcare forecast report provides an in-depth analysis of Myopic Macular Degeneration, offering comprehensive insights into the Myopic Macular Degeneration revenue trends,

All 5 Releases


More Releases for Biliary

Global Metal Pancreatic Biliary Stent Market Size by Application, Type, and Geog …
According to Market Research Intellect, the global Metal Pancreatic Biliary Stent market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period. The metal pancreatic biliary stent market is witnessing consistent growth due to the rising prevalence of
Major Market Share Shift in Biliary Catheters Industry: Advancements In Biliary …
What Is the Forecasted Market Size and Growth Rate for the Biliary Catheters Market? The market size for biliary catheters has experienced robust growth in recent years. There is an expected growth from $3.42 billion in 2024 to $3.75 billion in 2025, corresponding to a compound annual growth rate (CAGR) of 9.7%. Factors like increased occurrences of biliary tract ailments, the popularity of minimally invasive procedures, a growing aging population, more
Primary Biliary Cholangitis Treatment Market
Primary Biliary Cholangitis Treatment Market Global Primary Biliary Cholangitis Treatment Market Expected to Reach US$ YY Million by 2030, Growing at a CAGR of YY%: Market Insights and Dynamics The Global Primary Biliary Cholangitis Treatment Market, which reached US$ YY billion in 2022, is anticipated to achieve US$ YY million by 2030, exhibiting a robust CAGR of YY% during the forecast period from 2024 to 2031. Primary Biliary Cholangitis (PBC), formerly known as
Biliary Stents Market - Unleashing Flow: Empowering Biliary Health with Innovati …
Newark, New Castle, USA - new report, titled Biliary Stents Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Biliary Stents market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Biliary Stents market. The report offers an overview of the market, which
High Prevalence of Biliary Diseases Across the Globe is Driving the Biliary Sten …
Stent is referred as plastic or metal tube inserted in human body into lumen or duct to keep the passage open. Various types of stents such as expandable stents and simple plastic stents are used for various purposes. Different types of stents such as coronary, vascular, and biliary stents are employed for various purposes. ‘Biliary’ is referred to the bile duct, which is a long tube-like structure carrying bile fluid.
Rise in Surgical Procedures of Biliary Diseases is Expected to Boost the Biliary …
Stent is referred as plastic or metal tube inserted in human body into lumen or duct to keep the passage open. Various types of stents such as expandable stents and simple plastic stents are used for various purposes. Different types of stents such as coronary, vascular, and biliary stents are employed for various purposes. ‘Biliary’ is referred to the bile duct, which is a long tube-like structure carrying bile fluid.